Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias

Brain

Volumn 137, Issue 9, 2014, Pages 2509-2521

  Foster, Vincent ^a   Oakley, Arthur E ^a   Slade, Janet Y ^a   Hall, Roslyn ^a   Polvikoski, Tuomo M ^a   Burke, Matthew ^a   Thomas, Alan J ^a   Khundakar, Ahmad ^a   Allan, Louise M ^a   Kalaria, Raj N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Ageing; Alzheimer's disease; Executive function; Post stroke dementia; Prefrontal cortex; Stroke; Vascular dementia

Indexed keywords

NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN SMI31; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; BRAIN ATROPHY; BRAIN TISSUE; CAMBRIDGE COGNITION EXAMINATION; CELL DENSITY; CELL SIZE; CELL VOLUME; CEREBROVASCULAR ACCIDENT; CLINICAL DEMENTIA RATING; COGNITION; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); FRONTAL LOBE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MEMORY; MORPHOMETRICS; MULTIINFARCT DEMENTIA; NEOCORTEX; NEUROLOGIC EXAMINATION; ORBITAL CORTEX; ORIENTATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; STEREOLOGY;

AGEING; ALZHEIMER'S DISEASE; EXECUTIVE FUNCTION; POST-STROKE DEMENTIA; PREFRONTAL CORTEX; STROKE; VASCULAR DEMENTIA;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRIEF PSYCHIATRIC RATING SCALE; DEMENTIA, VASCULAR; FEMALE; HUMANS; MALE; PREFRONTAL CORTEX; PROSPECTIVE STUDIES; PYRAMIDAL CELLS;

EID: 84906691756     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu172     Document Type: Article

References (60)

1. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M. Clinically defined vascular depression. Am J Psychiatry 1997; 154: 562-5.
2. Allan LM, Rowan EN, Firbank MJ, Thomas AJ, Parry SW, Polvikoski TM, et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain 2011; 134: 3716-27.
3. Allan LM, Rowan EN, Thomas AJ, Polvikoski TM, O'Brien JT, Kalaria RN. Long-term incidence of depression and predictors of depressive symptoms in older stroke survivors. Br J Psychiatry 2013; 203: 453-60.
4. Altieri M, Di Piero V, Pasquini M, Gasparini M, Vanacore N, Vicenzini E, et al. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004; 62: 2193-7.
5. Altieri M, Maestrini I, Mercurio A, Troisi P, Sgarlata E, Rea V, et al. Depression after minor stroke: prevalence and predictors. Eur J Neurol 2012; 19: 517-21.
6. Ballard C, McKeith I, O'Brien J, Kalaria R, Jaros E, Ince P, et al. Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Dis 2000; 11: 59-65.
7. Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA. Prospective followup study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors 475 years of age. Stroke 2003a; 34: 2440-4.
8. Ballard C, Stephens S, Kenny R, Kalaria R, Tovee M, O'Brien J. Profile of neuropsychological deficits in older stroke survivors without dementia. Dement Geriatr Cogn Disord 2003b; 16: 52-6.
9. Burke MC, Nelson L, Slade JY, Oakley AE, Khundakar AA, Kalaria RN. Morphometry of the hippocampal microvasculature in post-stroke and age-related dementias. Neuropathol Appl Neurobiol 2013; 40: 284-95.
10. Burton E, Ballard C, Stephens S, Kenny RA, Kalaria R, Barber R, et al. Hyperintensities and fronto-subcortical atrophy on MRI are substrates of mild cognitive deficits after stroke. Dement Geriatr Cogn Disord 2003; 16: 113-18.
11. Burton EJ, Kenny RA, O'Brien J, Stephens S, Bradbury M, Rowan E, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke 2004; 35: 1270-5.
12. Ching RP. Relationship between head mass and circumference in human adults. Technical report 2007. www.smf.org/docs/articles/pdf/ching techbrief.pdf (13 June 2014, date last accessed).
13. Cotter D, Hudson L, Landau S. Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disord 2005; 7: 358-69.
14. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, et al. Neuron number and size in prefrontal cortex of children with autism. JAMA 2011; 306: 2001-10.
15. Craggs LJ, Yamamoto Y, Ihara M, Fenwick R, Burke M, Oakley AE, et al. White matter pathology and disconnection in the frontal lobe in CADASIL. Neuropathol Appl Neurobiol 2013. [doi: 10.1111/nan.120 73, Epub ahead of print].
16. Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology 2012; 78: 1043-50.
17. Desmond DW, Moroney JT, Paik MC, Sano M, Mohr JP, Aboumatar S, et al. Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000; 54: 1124-31.
18. Firbank MJ, Burton EJ, Barber R, Stephens S, Kenny RA, Ballard C, et al. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging 2007; 28: 1664-9.
19. Freeman SH, Kandel R, Cruz L, Rozkalne A, Newell K, Frosch MP, et al. Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease. J Neuropathol Exp Neurol 2008; 67: 1205-12.
20. Gelber RP, Launer LJ, White LR. The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment. Curr Alzheimer Res 2012; 9: 664-72.
21. Gemmell E, Bosomworth H, Allan L, Hall R, Khundakar A, Oakley AE, et al. Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke 2012; 43: 808-14.
22. Giannakopoulos P, Hof PR, Michel JP, Guimon J, Bouras C. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Brain Res Rev 1997; 25: 217-45.
23. Gundersen HJ. The nucleator. J Microsc 1988; 151: 3-21.
24. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220-41.
25. Halliday GM, Double KL, Macdonald V, Kril JJ. Identifying severely atrophic cortical subregions in Alzheimer's disease. Neurobiol Aging 2003; 24: 797-806.
26. Harding AJ, Halliday GM, Cullen K. Practical considerations for the use of the optical disector in estimating neuronal number. J Neurosci Methods 1994; 51: 83-9.
27. Huppert FA, Brayne C, Gill C, Paykel ES, Beardsall L. CAMCOG-a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol 1995; 34 (Pt 4): 529-41.
28. Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol 2010; 119: 579-89.
29. Ishii N, Nishihara Y, Imamura T. Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 1986; 36: 340-5.
30. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000; 21: 321-30.
31. Kalaria RN, Ihara M. Dementia: vascular and neurodegenerative pathways- will they meet? Nat Rev Neurol 2013; 9: 487-8.
32. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004; 226: 75-80.
33. Khundakar A, Morris C, Oakley A, McMeekin W, Thomas AJ. Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression. Br J Psychiatry 2009; 195: 163-9.
34. Khundakar A, Morris C, Oakley A, Thomas AJ. Morphometric analysis of neuronal and glial cell pathology in the caudate nucleus in late-life depression. Am J Geriatr Psychiatry 2011; 19: 132-41.
35. Khundakar AA, Thomas AJ. Morphometric changes in early- and late-life major depressive disorder: evidence from postmortem studies. Int Psychogeriatr 2009; 21: 844-54.
36. Kirvell SL, Elliott MS, Kalaria RN, Hortobagyi T, Ballard CG, Francis PT. Vesicular glutamate transporter and cognition in stroke: a case-control autopsy study. Neurology 2010; 75: 1803-9.
37. Kohler S, Thomas AJ, Barnett NA, O'Brien JT. The pattern and course of cognitive impairment in late-life depression. Psychol Med 2010; 40: 591-602.
38. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996; 46: 154-9.
39. Kril JJ, Halliday GM, Svoboda MD, Cartwright H. The cerebral cortex is damaged in chronic alcoholics. Neuroscience 1997; 79: 983-98.
40. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005; 4: 752-9.
41. Love S, Barber R, Wilcock GK. Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease. Brain 1999; 122 (Pt 2): 247-53.
42. Molnar Z, Cheung AF. Towards the classification of subpopulations of layer V pyramidal projection neurons. Neurosci Res 2006; 55: 105-15.
43. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-5.
44. Pasquier F, Henon H, Leys D. Relevance of white matter changes to preand poststroke dementia. Ann N Y Acad Sci 2000; 903: 466-9.
45. Perry RH, Oakley AE. Newcastle brain map. In: Roberts G, Leigh P, Weinberger D, editors. Neuropsychiatric disorders. London: Wolfe publishing; 1993. p. 1-10.
46. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M. Clinical determinants of poststroke dementia. Stroke 1998; 29: 75-81.
47. Pohjasvaara T, Leskela M, Vataja R, Kalska H, Ylikoski R, Hietanen M, et al. Post-stroke depression, executive dysfunction and functional outcome. Eur J Neurol 2002; 9: 269-75.
48. Rajkowska G, Miguel-Hidalgo JJ, Dubey P, Stockmeier CA, Krishnan KRR. Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry 2005; 58: 297-306.
49. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085-98.
50. Salehi A, Verhaagen J, Dijkhuizen PA, Swaab DF. Co-localization of highaffinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 1996; 75: 373-87.
51. Savva GM, Stephan BC. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010; 41: e41-6.
52. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 1984; 134: 127-36.
53. Swartz RH, Stuss DT, Gao F, Black SE. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke 2008; 39: 822-30.
54. Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53: 647-54.
55. Thomas AJ, Kalaria RN, O'Brien JT. Depression and vascular disease: what is the relationship? J Affect Disord 2004; 79: 81-95.
56. Thune JJ, Uylings HB, Pakkenberg B. No deficit in total number of neurons in the prefrontal cortex in schizophrenics. J Psychiatr Res 2001; 35: 15-21.
57. Viskontas IV, Possin KL, Miller BL. Symptoms of frontotemporal dementia provide insights into orbitofrontal cortex function and social behavior. Ann N Y Acad Sci 2007; 1121: 528-45.
58. von Economo C. Cellular structure of the human cerebral cortex. Basel, Switzerland: Karger; 2009.
59. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003; 34: 806-12.
60. Yamamoto Y, Ihara M, Tham C, Low RW, Slade JY, Moss T, et al. Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke 2009; 40: 2004-11.